Osteoporosis Medications and Tufts Newsletter

[Guest guest]

Hello Suz and CR ALL:

Thanks for the topical summary -- about the subject

of " Osteoporosis in Men " , in the Tufts Health Newsletter!!

One item of interest that I wonder about, which

was summarized thus:

> * The drugs used to treat osteoporosis are

> equally effective in men as in women.

This topic has come under discussion previously,

and has been challenged (or at least questioned),

because of the hormonal differences that exist

between men and women. ALL drugs for osteoporosis?

Or just certain categories (which categories?)?

Yet most osteoporosis drugs today are non-hormonal.

Logically, they should work for men and women equally.

I am a man ... taking osteoporosis drugs (Fosamax)

that are proven in women. Tests on men are currently

being conducted, but no proven male test results are

solidly available at this time.

Could we see the actual paragraph in full context,

in order to clarify and fortify the point of

" equally effective in men as in women? Ie, see the

particular paragraph or section that contains

this information quoted in full within its own

specific native context?

Osteoporosis has been of sincere interest to many.

If we see a reputable source, such as Tufts University

publish it in their Health Newsletter, then we will

feel much better. :-) Thanks!

-- Warren

[Guest guest]

Oh dear. I knew you were going to call me out on that one, Warren! (heh heh) This wasn't much of an article, actually, but an interesting little "interview" with Orwoll, MD, professor of medicine at Oregon Health Sciences University. Maybe you could reach Dr. Orwoll???

The article only says this (and it is the concluding sentence): The good news, says Dr. Orwoll: "Just about all of the drugs that work to combat osteopororsis in women--Fosamax, Actonel, Forteo--are just as effective in men."

The Tufts Newsletter generally covers one or two topics in depth each month, and merely hits upon several others. Unfortunately, this wasn't one of their in-depth reports.

How are you doing with Fosamax? Any news to report yet?

oxoxo

Suz

[Guest guest]

Hello Suz and CR ALL:

The news is good about Fosamax. Yes, good improvement

(about 5 percent measured by DEXA in two years time),

for my osteoporosis. Most people will LOSE 2 or 3 percent

in that time. So the difference is about 8 percent --

significant for weak bones like mine.

I had osteoporosis PRIOR to CR, and it was the

medical testing I did when starting CR

that alerted me, along with your help Suz.

Thanks for your interest and personal commitment

to helping us (all).

-- Warren

========================= ==================

-----Original Message-----

From: Suzanne Cart [mailto:massuz@...]

Sent: Wednesday, July 30, 2003 12:26 PM

Subject: Re: [ ] Osteoporosis

Medications and Tufts Newsletter

Oh dear. I knew you were going to call me out

on that one, Warren! (heh heh). This wasn't

much of an article, actually, but an interesting

little " interview " with Orwoll, MD,

professor of medicine at Oregon Health Sciences

University. Maybe you could reach Dr. Orwoll???

The article only says this (and it is the

concluding sentence): The good news, says Dr. Orwoll:

" Just about all of the drugs that work to combat

osteopororsis in women--Fosamax, Actonel, Forteo--

are just as effective in men. "

The Tufts Newsletter generally covers one or two topics

in depth each month, and merely hits upon several others.

Unfortunately, this wasn't one of their in-depth reports.

How are you doing with Fosamax? Any news to report yet?

oxoxo

Suz